Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease.
about
Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung functionClinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic reviewComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementInfluence of diet and obesity on COPD development and outcomesCare dependency in patients with chronic obstructive pulmonary disease and heart failure - a secondary data analysis of German prevalence studies.Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE studyImpact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease.Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary DiseaseObesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD).Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers.Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.Should we treat obesity in COPD? The effects of diet and resistance exercise training.Year in review 2016: Chronic obstructive pulmonary disease and asthma.High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD.Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.Body mass index and chronic airflow limitation in a worldwide population-based study.Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia.Use of administrative medical databases in population-based research.Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice.Body weight and mortality in COPD: focus on the obesity paradox.Obesity in COPD: Revealed and Unrevealed Issues.Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease.Obesity and metabolic syndrome in COPD: is exercise the answer?Differences in respiratory muscle activity during cycling and walking do not influence dyspnea perception in obese patients with COPD.Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPDLungs, Bone Marrow, and Adipose Tissue. A Network Approach to the Pathobiology of Chronic Obstructive Pulmonary Disease
P2860
Q26740608-5E953E86-0D96-4C88-9F43-E8B3BED9115FQ26782630-4A28D5C6-81DF-4D44-817F-C280CB553172Q26799659-99736776-37CC-4BA8-B0FA-876B1B0ED83BQ27026426-2A4C1AE9-3603-4F75-94FC-4402D723E02BQ30678547-D158B1EF-EAF9-441A-86B3-AFD514679DE7Q30992068-5C97CB86-79D1-4FAC-88E7-CD774945D4D5Q34083585-CED9B177-1200-4D5D-A45C-9809BAF6B55EQ36336714-EB1C4F59-FE67-49BD-86C2-752E529074A0Q37109180-F3EF4259-EB0C-49B8-BFD1-E2679D108AD8Q37688530-1EFFC159-743A-4687-B11A-15097076866BQ38604671-886C22E5-46D0-467C-883E-E374253DC6FAQ38903266-BA741B9C-4A3E-4CFA-898F-9840C95D9894Q39216404-29A08644-AD49-4A82-B190-8E24913743AEQ39818617-37A32443-B13C-4F46-9E9B-76443E8F2A89Q40231525-D721105D-7ADF-4294-BE73-ED8CFFED6470Q40604549-80F974F1-5B7B-428D-B163-99597EE0D851Q40976537-CAA36485-2059-4171-941B-3DF28E22942AQ42712221-4455E749-D587-49D9-A19E-A41C141290DDQ44703807-6D374CDF-04F1-4711-A14C-FBA117655B28Q47106747-54F92004-50DD-45A0-8275-AE41A8B3B4A6Q47177659-EFBC0ABE-A50C-4C7D-BF50-B868FF1309E8Q47359885-D7027B83-6D04-47E0-899F-7CDA894ABC57Q47704314-EA0C8754-125F-4196-A681-45176A19025EQ47850975-9B103EAC-24C6-40CA-B073-32D3717FD7CCQ51691819-E2E6FB34-7CCC-463A-AD94-D7E49E89303DQ55212210-19563235-10B1-4772-AD89-5B317A5D6B39Q58614808-0FA9770B-5913-4BEE-8954-D72A5C29397EQ58840414-31DC4CBC-83CE-42E6-B1CB-CAA710782241
P2860
Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@ast
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@en
type
label
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@ast
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@en
prefLabel
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@ast
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@en
P2860
P356
P1476
Prevalence, risk factors, acti ...... obstructive pulmonary disease.
@en
P2093
Denis E O'Donnell
Nicholas T Vozoris
P2860
P304
P356
10.1155/2012/732618
P407
P577
2012-05-01T00:00:00Z